World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
65382
World Ranking
2395
National Ranking
1353

Research.com Recognitions

  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David H. Gutmann is affiliated with Washington University in St. Louis in the United States and has an extensive publication record primarily in the field of Medicine. Their work spans several subfields, including Neurology, Genetics, Immunology, Molecular Biology, and Epidemiology.

The scientist's research focuses on a range of topics connected to neuro-oncology, neurogenetics, and cancer neuroscience. These topics include:

  • Neurofibromatosis and Schwannoma Cases
  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Immune cells in cancer
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Meningioma and schwannoma management
  • Vascular Malformations Diagnosis and Treatment

David H. Gutmann frequently publishes in several key journals related to their specialties. These publication venues are:

  • Neuro-Oncology
  • Nature Communications
  • Neuro-Oncology Advances
  • Acta Neuropathologica Communications
  • bioRxiv (Cold Spring Harbor Laboratory)

The scientist has collaborated with numerous co-authors, some of the most frequent being:

  • Corina Anastasaki
  • Olivia Cobb
  • Jit Chatterjee
  • Michael J. Fisher
  • Michelle Monje

Among their recent scholarly contributions are the following papers:

  • Microglia states and nomenclature: A field at its crossroads (2022), published in Neuron
  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation (2021), published in Genetics in Medicine
  • Cancer neuroscience: State of the field, emerging directions (2023), published in Cell
  • Roadmap for the Emerging Field of Cancer Neuroscience (2020), published in Cell
  • Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation (2022), published in Genetics in Medicine

David H. Gutmann was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 2020.

Best Publications

  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

    Michele Ceccarelli;Floris P Barthel;Tathiane M Malta;Thais S Sabedot

  • The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

    David H. Gutmann;Arthur Aylsworth;John C. Carey;Bruce Korf

  • The role of microglia and macrophages in glioma maintenance and progression

    Dolores Hambardzumyan;David H Gutmann;Helmut Kettenmann

  • Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.

    Koji Yamanaka;Seung Joo Chun;Severine Boillee;Noriko Fujimori-Tonou

  • Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

    Allison King;David H. Gutmann

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Subtypes of medulloblastoma have distinct developmental origins

    Paul Gibson;Yiai Tong;Giles Robinson;Margaret C. Thompson

  • Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

    Ling-Hui Zeng;Lin Xu;David H. Gutmann;Michael Wong

  • Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

    Tanya N. Basu;David H. Gutmann;Jonathan A. Fletcher;Thomas W. Glover

  • International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

    Rosalie E. Ferner;David H. Gutmann

  • Neurofibromatosis type 1 revisited.

    Virginia C Williams;John Lucas;Michael A Babcock;David H Gutmann

  • Challenges to curing primary brain tumours

    Kenneth Aldape;Kevin M Brindle;Louis Chesler;Rajesh Chopra

  • Neurofibromatosis type 1.

    David H. Gutmann;Rosalie E. Ferner;Robert H. Listernick;Bruce R. Korf

  • Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations

    Robert Listernick;Rosalie E. Ferner;Grant T. Liu;Grant T. Liu;David H. Gutmann

  • The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

    Helen Morrison;Larry S. Sherman;James Legg;Fatima Banine

  • Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force.

    R Listernick;DN Louis;RJ Packer;DH Gutmann

  • Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma

    Zhihong Chen;Zhihong Chen;Xi Feng;Cameron J. Herting;Virginia Alvarez Garcia

  • Neurofibromatosis type 1: a multidisciplinary approach to care.

    Angela C Hirbe;David H Gutmann

  • Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

    Erik J. Uhlmann;Michael Wong;Rebecca L. Baldwin;M. Livia Bajenaru

  • cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product

    Douglas A. Marchuk;Ann M. Saulino;Roxanne Tavakkol;Manju Swaroop

Frequent Co-Authors

Arie Perry
Arie Perry University of California, San Francisco
Abhijit Guha
Abhijit Guha University of Toronto
Michael Fisher
Michael Fisher University of Manchester
Roger J. Packer
Roger J. Packer Children’s National Health System
Bruce R. Korf
Bruce R. Korf University of Alabama at Birmingham
Francis S. Collins
Francis S. Collins National Institutes of Health
Marco Giovannini
Marco Giovannini University of California, Los Angeles
feng gao
feng gao Duke University
Feng Gao
Feng Gao Linköping University
Kathryn N. North
Kathryn N. North University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but traditional medical school isn’t your path, there are several related online degrees and flexible career choices to consider. Nursing is a popular option. For those with a bachelor’s degree in another field, a direct entry msn online program can be a rapid way to enter advanced nursing roles without prior nursing experience.

Some students look for programs that ease the admission process. Seeking out the easiest bsn program to get into can open doors for those who may not meet highly competitive requirements but want to pursue a nursing career.

Not all healthcare roles require patient care. You might explore in-demand administrative fields by researching the best online medical billing and coding schools that offer flexible schedules and financial aid, making entry more accessible.

Finally, if standardized tests are a barrier, some absn programs that don't require teas or HESI exams could provide a smoother pathway into nursing. Each of these alternatives offers unique opportunities to build a rewarding career in medicine or health science.

Best Scientists Citing David H. Gutmann

Trending Scientists

Recently Published Articles